Lumicell Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
59
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$198M
- Investors
-
14
Lumicell General Information
Description
Developer of oncology surgical devices designed to improve the way cancer surgery is performed. The company's devices use an optical contrast agent that targets the tumor microenvironment to fluoresce near cancer cells at the tumor margin along with a single-cell resolution imaging device to fit into the lumpectomy cavity and scan for residual cancer at the margins, enabling surgeons to remove cancer cells in the cavity walls in real-time during surgery.
Contact Information
Website
www.lumicell.comCorporate Office
- One Newton Place, 275 Washington Street
- Suite 200
- Newton, MA 02458
- United States
Corporate Office
- One Newton Place, 275 Washington Street
- Suite 200
- Newton, MA 02458
- United States
Lumicell Timeline
Lumicell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 06-May-2025 | $198M | Completed | Clinical Trials - General | ||
| 13. Later Stage VC | 24-Jul-2024 | Completed | Clinical Trials - General | |||
| 12. Later Stage VC (Series D) | 26-Jul-2023 | Completed | Clinical Trials - General | |||
| 11. Debt - PPP | 15-Apr-2020 | Completed | Clinical Trials - General | |||
| 10. Grant | 30-Jun-2019 | Completed | Clinical Trials - General | |||
| 9. Later Stage VC (Series D) | 20-Dec-2018 | Completed | Clinical Trials - General | |||
| 8. Later Stage VC (Series C) | 17-Oct-2017 | Completed | Clinical Trials - General | |||
| 7. Grant | 01-Jan-2016 | Completed | Clinical Trials - General | |||
| 6. Grant | 31-Mar-2014 | $494K | $5.27M | Completed | Clinical Trials - General | |
| 5. Later Stage VC (Series B) | 25-Feb-2014 | $1.56M | $5.27M | Completed | Clinical Trials - General |
Lumicell Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-2 | ||||||||
| Series D-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 418,603 | $0.001000 | 8% | $6.75 | $6.75 | $6.75 | 3.89% | |
| Series A | 1,207,322 | $0.001000 | 8% | $3.26 | $3.26 | $3.26 | 11.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lumicell Comparisons
Industry
Financing
Details
Lumicell Competitors (16)
One of Lumicell’s 16 competitors is Seno Medical, a Private Equity-Backed company based in San Antonio, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Seno Medical | Private Equity-Backed | San Antonio, TX | ||||
| Blaze Bioscience | Venture Capital-Backed | Seattle, WA | ||||
| UE LifeSciences | Venture Capital-Backed | Philadelphia, PA | ||||
| Avelas Biosciences | Venture Capital-Backed | San Diego, CA | ||||
| IceCure Medical | Corporate Backed or Acquired | Caesarea, Israel |
Lumicell Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lumicell Patents
Lumicell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230133106-A1 | Calibration tip for imaging devices | Inactive | 04-Nov-2021 | ||
| US-20230139704-A1 | Optical fiber fixtures for imaging devices | Pending | 04-Nov-2021 | ||
| US-20230134454-A1 | Sealed imaging devices | Inactive | 04-Nov-2021 | ||
| US-20230138742-A1 | Sterile barrier for medical imaging device | Pending | 04-Nov-2021 | ||
| EP-3905948-A1 | System and method for thresholding for residual cancer cell detection | Pending | 31-Dec-2018 | A61B90/361 |
Lumicell Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lumicell Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Claridge Venture Partners | Family Office | Minority | ||
| Burch Creative Capital | Venture Capital | Minority | ||
| Kinled Holding | Family Office | Minority | ||
| reverse entropy ventures | Venture Capital | Minority | ||
| Rivas Capital | Venture Capital | Minority |
Lumicell FAQs
-
When was Lumicell founded?
Lumicell was founded in 2008.
-
Where is Lumicell headquartered?
Lumicell is headquartered in Newton, MA.
-
What is the size of Lumicell?
Lumicell has 59 total employees.
-
What industry is Lumicell in?
Lumicell’s primary industry is Surgical Devices.
-
Is Lumicell a private or public company?
Lumicell is a Private company.
-
What is Lumicell’s current revenue?
The current revenue for Lumicell is .
-
How much funding has Lumicell raised over time?
Lumicell has raised $333M.
-
Who are Lumicell’s investors?
Claridge Venture Partners, Burch Creative Capital, Kinled Holding, reverse entropy ventures, and Rivas Capital are 5 of 14 investors who have invested in Lumicell.
-
Who are Lumicell’s competitors?
Seno Medical, Blaze Bioscience, UE LifeSciences, Avelas Biosciences, and IceCure Medical are some of the 16 competitors of Lumicell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
